Introduction
Materials and methods
Data sources and search strategy
Database | Search Strategy |
---|---|
PubMed | (((((((ED[Title/Abstract]) OR critical*[Title/Abstract]) OR urgent[Title/Abstract]) OR ICU[Title/Abstract]) OR emergen*[Title/Abstract])) AND (((((((((((((“King Vision”[Title/Abstract]) OR McGrath[Title/Abstract]) OR Glidescope[Title/Abstract]) OR C-MAC[Title/Abstract]) OR Airtraq[Title/Abstract]) OR “Airway Scope”[Title/Abstract]) OR “Pentax AWS”[Title/Abstract]) OR “TruView PCD”[Title/Abstract]) OR “Storz DCI”[Title/Abstract]) OR BERCI[Title/Abstract]) OR “video laryngoscopy”) OR “video laryngoscope”[Title/Abstract]) OR videolaryngoscop*[Title/Abstract]) |
Embase | (‘videolaryngoscopy’:ab,ti OR ‘videolaryngoscope’:ab,ti OR ‘video laryngoscopy’:ab,ti OR ‘video laryngoscope’:ab,ti OR ‘king vision’:ab,ti OR glidescope:ab,ti OR mcgrath:ab,ti OR ‘c mac’:ab,ti OR airtraq:ab,ti OR ‘airway scope’:ab,ti OR ‘pentax aws’:ab,ti OR truview:ab,ti OR ‘storz dci’:ab,ti OR berci:ab,ti) AND (emergen*:ab,ti,kw OR critical*:ab,kw,ti OR icu:ab,kw,ti OR ed.:ab,ti,kw) AND (‘case report’/de OR ‘clinical article’/de OR ‘clinical trial’/de OR ‘comparative study’/de OR ‘controlled clinical trial’/de OR ‘controlled study’/de OR ‘crossover procedure’/de OR ‘human’/de OR ‘human experiment’/de OR ‘intermethod comparison’/de OR ‘major clinical study’/de OR ‘meta analysis’/de OR ‘multicenter study’/de OR ‘observational study’/de OR ‘prospective study’/de OR ‘randomized controlled trial’/de OR ‘randomized controlled trial (topic)’/de OR ‘retrospective study’/de OR ‘total quality management’/de) |
Cochrane Central Register of Controlled Trials | ‘videolaryngoscopy or videolaryngoscope or videolaryngoscopic or videolaryngoscopes or “video laryngoscopy” or “video laryngoscope” or “video laryngoscopic” or “video laryngoscopes” or “King Vision” or McGrath or Glidescope or C-MAC OR Airtraq or “Airway Scope” or “Pentax AWS” or “TruView PCD” or “Storz DCI” or BERCI in Title, Abstract, Keywords and emergent or critical or ICU or urgent in Title, Abstract, Keywords’ |
Web of Science | TI = (videolaryngoscop* OR “video laryngoscop*” OR “King Vision” OR Glidescope OR McGrath OR C-MAC OR Airtraq OR “Airway Scope” OR “Pentax AWS” OR “TruView PCD” OR “Storz DCI” OR “BERCI” OR “AP Advance”) AND TS = (urgent or ICU or ED or critical* or emergen*) Index = SCI-EXPANDED, SSCI, A&HCL, ESCI Timespan = All years |
Eligibility criteria
Study selection and data extraction
Primary and secondary outcomes
Risk of bias assessment
Statistical analysis
Results
Characteristic of included studies
Studies | Type of studies | Settings | Number (VL/DL) | Participants | Type of VLs | Experience of operators | Difficult Airway Excluded | Anesthesia |
---|---|---|---|---|---|---|---|---|
Campagne et al., 2008 | Prospective OS | ED | 280 (63/210) | Adults | GVL | Unclear | Unknown | Unclear |
De Jong et al., 2013 | Prospective before–after OS | ICU | 210 (140/70) | Adults | McGrath MAC | Most are inexperienced | No | Most RSI |
Driver et al., 2016 | RCT | ED | 198 (103/95) | Adults | C-MAC | Most experienced | No | Most RSI |
Driver et al., 2018 | OS | ED | 823 (428/395) | Adults | C-MAC | Inexperienced | Unclear | Most RSI |
Gao et al., 2018 | RCT | ICU | 163 (81/82) | Adults | UEscope | Experienced | No | Sedatives without any NMBA |
Goksu et al., 2016 | RCT | ED | 150 (75/75) | Age ≥ 16 years | C-MAC | Most inexperienced (ED residents and attending physicians) | No | All used RSI except patients with cardiac arrest. |
Griesdale et al., 2012 | RCT | ICU | 40 (20/20) | Age ≥ 16 years without cardiac arrest. Patients with cervical spine precautions, anticipated difficult intubation, oxygen saturation < 90%, or systolic blood pressure < 80 mmHg despite resuscitation were excluded. | GVL | Inexperienced | Yes | All RSI |
Hypes et al., 2016 | OS | ICU | 809 (673/136) | Nasotracheal intubations, flexible fiberoptic bronchoscopy or supraglottic devices, and intubations performed by medical students or attending physicians were excluded. | GVL, C-MAC, KingVision, and McGrath MAC | Inexperienced | No | Most RSI |
Janz et al., 2016 | RCT | ICU | 150 (74/76) | Adult | McGrath MAC and GVL | Inexperienced | No | All used sedatives and most used NMBAs |
Khandelwal et al., 2014 | Retrospective | In-hospital, out-of-OR | 420 (49/371) | Adult | GVL | Most experienced | No | Unclear |
Kim et al., 2016 | RCT | ED | 140 (71/69) | Adult patients with CPR | GVL | Experienced | No | None |
Kory et al., 2013 | Retrospective | ICU and medical or surgical wards | 138 (78/50) | Not mentioned | GVL | Inexperienced operators | No | NMBAs were not used routinely. |
Lakticova et al., 2015 | OS | ICU | 392 (252/140) | Not mentioned | GVL | Relatively inexperienced | No | Graded intravenous sedation without NMBAs |
Lascarrou et al., 2017 | RCT | ICU | 371 (186/185) | Adult patients without CPR | MaGrath Mac | Most inexperienced | No | All RSI |
Lee et al., 2014 | Retrospective | General wards | 229 (121/108) | Patients in general wards with acute deterioration in clinical status or requiring CPR | GVL or AirwayScope | Inexperienced (50.2%) and experienced (49.8%) | Unclear | Probably none |
Noppens et al., 2012 | Prospective, before-after study | Anesthetist-lead surgical ICU | 230 (117/113) | Adult | C-MAC | Most experienced | No | All used RSI except patients with cardiac arrest. |
Okamoto et al., 2018 | Multicentre, prospective, OS | ED | 3360 (613/2747) | Adult patients with cardiac arrest | C-MAC,McGrath, AirwayScope, and GVL | Most inexperienced | No | Probably none |
Park et al., 2015 | Historically controlled clinical design | ED | 83 (49/34) | All adults out-of-hospital cardiac arrest patients requiring emergency tracheal intubation during CPR in the ED | GVL | Inexperienced | Unclear | Probably none |
Sakles et al., 2015 | Retrospective | ED | 3425 (1895/1530) | All patients in whom intubation attempts were made in the ED by EM residents with a DL or VL. | GVL or C-MAC | Inexperienced | No | Most RSI |
Silverberg et al., 2015 | quasi-RCT | ICU | 117 (57/60) | Patients with a known history of difficult intubation, presence of limited mouth opening, oropharyngeal masses, or swollen tongue, or oxygen saturation less than 92% after bag valve mask ventilation were excluded. | GVL | Inexperienced | Yes | Sedatives were chosen as needed, but NMBA was not used. |
Sulser et al., 2016 | RCT | ED | 147 (74/73) | Adult patients without CPR | C-MAC | Experienced | No | As needed |
Vassiliadis et al., 2015 | Retrospective | ED | 619 (353/266) | ED patients | C-MAC | Most inexperienced | No | Most RSI |
Yeatts et al., 2013 | RCT | ED | 623 (303/320) | CPR patients were excluded. | GVL | Experienced | No | All RSI |
Risk of bias assessment for included studies
RCTs | Study Authors | Random sequence generation | Allocation concealment | Blinding of participants and personnela | Blinding of outcome assessmenta | Incomplete outcome data | Selective reporting | Other bias | Overall |
Driver et al., 2016 | Low | Low | Low | Low | Low | Low | Low | Low | |
Gao et al., 2018 | Unclear | Unclear | Low | Low | Low | Low | Low | Unclear | |
Goksu et al., 2016 | Low | Low | Low | Low | Low | Low | Low | Low | |
Griesdale et al., 2012 | Low | Low | Low | Low | Low | Low | Low | Low | |
Janz et al., 2016 | Low | Low | Low | Low | Low | Low | Low | Low | |
Kim et al., 2016 | Low | Lowb | low | low | Low | low | low | Low | |
Lascarrou et al., 2017 | Low | Low | Low | Low | Low | Low | Low | Low | |
Silverberg et al., 2015 | Highc | Unclear | Low | Low | Low | Low | Low | High | |
Susler et al., 2016 | Low | Low | Low | Low | Low | Low | Low | Low | |
Yeatts et al., 2013 | Low | Low | Low | Low | Highd | Low | Low | High | |
non-RCTs | Study Authors | Confounding | Selection of participants into study | Classification of interventions | Deviations from intended interventions | Missing data | Measurement of outcomes | Selection of reported results | Overall |
Campagne et al., 2008 | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | |
De Jong et al., 2013 | Seriouse | Moderate | Moderate | Moderate | Moderate | Seriousf | Low | Serious | |
Driver et al., 2018 | Moderate | Moderate | Moderate | Moderate | Moderate | Low | Low | Moderate | |
Hypes et al., 2016 | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Low | Moderate | |
Khandelwal et al., 2014 | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Low | Moderate | |
Kory et al., 2013 | Moderate | Moderate | Moderate | Moderate | Moderate | Seriousg | Low | Serious | |
Lakticova et al., 2015 | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Low | Moderate | |
Lee et al., 2014 | Seriouse | Moderate | Moderate | Moderate | Moderate | Moderate | Low | Serious | |
Noppens et al., 2012 | Seriouse | Moderate | Moderate | Moderate | Moderate | Moderate | Low | Serious | |
Okamoto et al., 2018 | Serious eh | Moderate | Moderate | moderate | Moderate | Moderate | Low | Serious | |
Park et al., 2015 | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Low | Moderate | |
Sakles et al., 2015 | Moderate | Moderate | Moderate | Moderate | Moderate | Serious | Low | Serious | |
Vassiliadis et al., 2015 | Moderate | Moderate | Moderate | Moderate | Moderate | Seriousf | Low | Serious |
Rate of EI
Other adverse events
Outcomes | Studies, N | Participants, N | Heterogeneity | Heterogeneity Statistical method | Effect Estimate | P values |
---|---|---|---|---|---|---|
Rate of EI | 18 | 11,187 | P = 0.05; I2 = 39% | RR (M-H, Fixed, 95% CI) | 0.24 [0.18, 0.32] | P < 0.01 |
Rate of EI (RCT) | 7 | 1232 | P = 0.70; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.27 [0.13, 0.57] | P < 0.01 |
Rate of EI (non-RCT) | 11 | 9955 | P = 0.01; I2 = 57% | RR (M-H, Fixed, 95% CI) | 0.24 [0.18, 0.32] | P < 0.01 |
Rate of EI (CPR) | 4 | 3723 | P = 0.44; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.27 [0.15, 0.49] | P < 0.01 |
Rate of EI (non-CPR) | 15 | 7464 | P = 0.03; I2 = 46% | RR (M-H, Fixed, 95% CI) | 0.23 [0.17, 0.31] | P < 0.01 |
Rate of EI (experienced) | 5 | 1100 | P = 0.45; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.44 [0.17, 1.15] | P = 0.09 |
Rate of EI (inexperienced) | 12 | 9807 | P = 0.02; I2 = 50% | RR (M-H, Fixed, 95% CI) | 0.23 [0.17, 0.31] | P < 0.01 |
Rate of EI (unknown expertise) | 1 | 280 | Not applicable | RR (M-H, Fixed, 95% CI) | 0.38 [0.02, 6.94] | P = 0.51 |
Incidence of hypoxemia | 4 | 1548 | P = 0.35; I2 = 8% | RR (M-H, Fixed, 95% CI) | 0.85 [0.69, 1.05] | P = 0.14 |
Incidence of hypoxemia (RCT) | 2 | 510 | P = 0.34; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.91 [0.56, 1.47] | P = 0.70 |
Incidence of hypoxemia (non-RCT) | 2 | 1038 | P = 0.13; I2 = 56% | RR (M-H, Fixed, 95% CI) | 0.83 [0.66, 1.05] | P = 0.13 |
Incidence of hypoxemia (experienced) | 2 | 393 | P = 0.70; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.05 [0.77, 1.43] | P = 0.76 |
Incidence of hypoxemia (inexperienced) | 2 | 1155 | P = 0.89; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.71 [0.53, 0.96] | P = 0.03 |
Incidence of severe hypoxemia | 8 | 1739 | P = 0.26; I2 = 22% | RR (M-H, Fixed, 95% CI) | 1.13 [0.83, 1.52] | P = 0.44 |
Incidence of severe hypoxemia (RCT) | 4 | 787 | P = 0.18; I2 = 39% | RR (M-H, Fixed, 95% CI) | 1.11 [0.66, 1.87] | P = 0.39 |
Incidence of severe hypoxemia (non-RCT) | 4 | 952 | P = 0.26; I2 = 26% | RR (M-H, Fixed, 95% CI) | 1.13 [0.78, 1.64] | P = 0.52 |
Incidence of severe hypoxemia (experienced) | 2 | 393 | P = 0.46; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.16 [0.62, 2.16] | P = 0.65 |
Incidence of severe hypoxemia (inexperienced) | 6 | 1346 | P = 0.14; I2 = 40% | RR (M-H, Fixed, 95% CI) | 1.12 [0.79, 1.58] | P = 0.53 |
Incidence of aspiration | 13 | 4634 | P = 0.98; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.83 [0.60, 1.16] | P = 0.28 |
Incidence of aspiration (RCT) | 7 | 1751 | P = 0.79; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.90 [0.52, 1.58] | P = 0.72 |
Incidence of aspiration (non-RCT) | 6 | 2883 | P = 0.92; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.80 [0.53, 1.21] | P = 0.28 |
Incidence of aspiration (CPR) | 1 | 140 | Not applicable | RR (M-H, Fixed, 95% CI) | 5.58 [0.25, 126.46] | P = 0.28 |
Incidence of aspiration (non-CPR) | 13 | 4494 | P = 0.97; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.83 [0.59, 1.16] | P = 0.27 |
Incidence of aspiration (experienced) | 6 | 1769 | P = 0.88; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.65 [0.32, 1.32] | P = 0.24 |
Incidence of aspiration (inexperienced) | 7 | 2865 | P = 0.92; I2 = 0% | RR (M-H, Fixed, 95% CI) | 0.90 [0.61, 1.31] | P = 0.57 |
Incidence of new-onset CA | 7 | 2433 | P = 0.20; I2 = 31% | RR (M-H, Fixed, 95% CI) | 1.52 [0.63, 3.66] | P = 0.35 |
Incidence of new-onset CA (RCT) | 4 | 795 | P = 0.56; I2 = 0% | RR (M-H, Fixed, 95% CI) | 3.51 [0.73, 16.92] | P = 0.12 |
Incidence of new-onset CA (non-RCT) | 3 | 1638 | P = 0.09; I2 = 58% | RR (M-H, Fixed, 95% CI) | 0.86 [0.27, 2.70] | P = 0.79 |
Incidence of new-onset CA (experienced) | 1 | 163 | Not applicable | RR (M-H, Fixed, 95% CI) | 3.04 [0.13, 73.46] | P = 0.49 |
Incidence of new-onset CA (inexperienced) | 6 | 2270 | P = 0.14; I2 = 43% | RR (M-H, Fixed, 95% CI) | 1.42 [0.57, 3.56] | P = 0.45 |
24 h-mortality | 6 | 1477 | P = 0.82; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.29 [0.98, 1.69] | P = 0.07 |
24 h-mortality (RCT) | 3 | 646 | P = 1.00; I2 = 0% | RR (M-H, Fixed, 95% CI) | 3.06 [0.49, 19.25] | P = 0.23 |
24 h-mortality (non-RCT) | 3 | 831 | Not applicable | RR (M-H, Fixed, 95% CI) | 1.23 [0.94, 1.62] | P = 0.13 |
24 h-mortality (CPR) | 1 | 229 | Not applicable | RR (M-H, Fixed, 95% CI) | 1.23 [0.94, 1.62] | P = 0.13 |
24 h-mortality (non-CPR) | 5 | 1248 | P = 1.00; I2 = 0% | RR (M-H, Fixed, 95% CI) | 3.06 [0.49, 19.25] | P = 0.23 |
24 h-mortality (experienced) | 1 | 164 | Not applicable | RR (M-H, Fixed, 95% CI) | 3.07 [0.13, 74.35] | P = 0.49 |
24 h-mortality (inexperienced) | 5 | 1313 | P = 0.73; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.27 [0.97, 1.67] | P = 0.08 |
28 d-mortality | 7 | 1821 | P = 0.98; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.04 [0.92, 1.19] | P = 0.52 |
28 d-mortality (RCT) | 5 | 1382 | P = 0.90; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.04 [0.86, 1.26] | P = 0.66 |
28 d-mortality (non-RCT) | 2 | 439 | P = 0.82; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.04 [0.88, 1.23] | P = 0.62 |
28 d-mortality (CPR) | 1 | 229 | Not applicable | RR (M-H, Fixed, 95% CI) | 1.03 [0.86, 1.23] | P = 0.76 |
28 d-mortality (non-CPR) | 6 | 1592 | P = 0.95; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.05 [0.89, 1.24] | P = 0.57 |
28 d-mortality (experienced) | 2 | 821 | P = 0.94; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.22 [0.83, 1.79] | P = 0.32 |
28 d-mortality (inexperienced) | 5 | 1000 | P = 0.99; I2 = 0% | RR (M-H, Fixed, 95% CI) | 1.01 [0.88, 1.16] | P = 0.88 |